Clinical Research and Trials—A “Nonessential” Victim of the COVID-19 Pandemic?

• Published in: The American journal of gastroenterology Vol. 115; no. 6; pp. 946 - 947
• Main Authors: Peyrin-Biroulet, Laurent, Ananthakrishnan, Ashwin N.
• Format: Journal Article
• Language: English
• Published: United States Wolters Kluwer 01.06.2020; Wolters Kluwer Health Medical Research, Lippincott Williams & Wilkins; Lippincott, Williams & Wilkins
• Subjects: Betacoronavirus - isolation & purification; Black swan event; Clinical trials; Clinical Trials as Topic - organization & administration; Colonoscopy; Coronavirus Infections - epidemiology; Coronavirus Infections - prevention & control; Coronavirus Infections - transmission; Coronaviruses; Correspondence; COVID-19; Disease transmission; Disease Transmission, Infectious - prevention & control; Emerging diseases; Gastroenterology; Gastroenterology - methods; Human health and pathology; Humans; Infection Control - methods; Inflammatory bowel disease; Life Sciences; Microbiology and Parasitology; Pandemics; Pandemics - prevention & control; Patient Care Management - methods; Patient Care Management - standards; Patients; Pneumonia, Viral - epidemiology; Pneumonia, Viral - prevention & control; Pneumonia, Viral - transmission; Research Subjects; SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2; Virology

Often, these are patients who have experienced prolonged disease-related morbidity in addition to potential treatment-related effects (such as with persistent corticosteroid use in patients with inflammatory bowel disease [IBD]). [...]solutions could include greater use of remote or teleconsenting o...